Bath & Body Works, Inc.
BBWIConsumer Cyclical Specialty Retail
Bath & Body Works, Inc.’s revenue for fiscal 2026 (year ended January 2026) was $7.3 billion, roughly unchanged from fiscal 2025.
- Revenue
- −1.07%
- EPS
- −48.6%
- Free cash flow
- n/m
- Total debt
- −13.4%
Quarter to October 2026, against a year earlier
After hours trading: 18.91, unchanged, last trade 4:00pm Eastern.
Follow BBWI
Alert me
Ratios over time Q4 FY26 to Q3 FY27
Returns on capital
ROIC was 37.2% in Q3 FY27, the lowest of these four quarters.
| Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 | |
|---|---|---|---|---|
| ROE | −48.8% | −56.3% | −60.0% | −54.9% |
| ROIC | 42.4% | 43.2% | 42.7% | 37.2% |
Debt
Net debt is 18.48× a year’s EBITDA.
| Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 | |
|---|---|---|---|---|
| Net debt / EBITDA | 4.4× | 9.6× | 10.3× | 18.5× |
Cash cycle, in days
Customers pay in 9 days, inventory is held 116 days and suppliers are paid in 83. Cash is tied up for 42 days between paying for goods and being paid.
| Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 | |
|---|---|---|---|---|
| Cash cycle | 30 | 25 | 27 | 42 |
| Days to pay suppliers | 41 | 49 | 61 | 83 |
| Days to be paid | 9 | 5 | 8 | 9 |
Per share, from Q4 FY26
Since Q4 FY26, per share: free cash flow has grown 33.6%; revenue has grown 2.1%.
| Q4 FY26 | Q1 FY27 | Q2 FY27 | Q3 FY27 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 1.1× | 1.2× | 1.3× |
| Revenue | 1.0× | 1.0× | 1.0× | 1.0× |
| Oct '26 From the 10-Q filed 19 Nov | Jul '26 | Apr '26 | Jan '26 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
6 | 6 | 6 | 6 |
+8 more TTM periods Free account |
| (54.94%) | (60.05%) | (56.33%) | (48.76%) | ||
| 14.73% | 15.67% | 14.77% | 13.06% | ||
ROIC |
37.18% | 42.72% | 43.17% | 42.39% | |
Return on Tangible Assets |
53.61% | 53.90% | 44.66% | 41.74% | |
Average Days of Receivables |
8.98 | 7.80 | 4.94 | 9.01 | |
Free Cash Flow per Share |
5.61 | 5.21 | 4.61 | 4.20 | |
Free Cash Flow |
1,128.00 | 1,048.00 | 926.00 | 874.00 | |
Capital Expenditures |
— | (225.00) | (232.00) | (228.00) | |
| Other line items | |||||
Cash ROIC |
43.79% | 31.25% | 28.04% | 24.51% | |
Accounts Receivable Turnover |
41.58 | 50.60 | 72.09 | 37.88 | |
Accounts Payable Turnover |
4.75 | 6.48 | 8.16 | 10.22 | |
Inventory Turnover |
3.18 | 4.33 | 4.98 | 5.73 | |
Average Days of Payables |
82.94 | 61.26 | 49.41 | 41.38 | |
Days of Inventory on Hand |
115.99 | 80.01 | 69.36 | 62.20 | |
Tax Rate |
(0.19) | (0.20) | (0.19) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
27.92% | 27.39% | 27.36% | 28.30% | |
Share Based Compensation of Revenue |
0.32% | 0.32% | 0.40% | 0.43% | |
Interest Coverage |
4.46 | 4.49 | 4.19 | 4.08 | |
Operating CF/Net income |
1.52 | 1.63 | 1.59 | 1.70 | |
Depreciation/Fixed assets |
0.22 | 0.22 | 0.23 | 0.23 | |
Capex/Depreciation |
0.00 | (0.91) | (0.92) | (0.90) | |
Revenue per Share |
35.79 | 35.87 | 36.04 | 35.05 | |
Operating CF per Share |
5.61 | 6.33 | 5.76 | 5.30 | |
Capex per Share |
0.00 | (1.12) | (1.15) | (1.10) | |
Capex to Sales |
0.00 | 0.03 | 0.03 | 0.03 |